A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease

NCT04799158 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

458

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Erosive Gastro-Esophageal Reflux Disease
Heartburn

Interventions

DRUG: Vonoprazan
DRUG: Placebo

Sponsor

Phathom Pharmaceuticals, Inc.